Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Parkinson's Disease

  Free Subscription

Articles published in Neurobiol Dis

Retrieve available abstracts of 108 articles:
HTML format

Single Articles

    May 2020
  1. HEATON GR, Landeck N, Mamais A, Nalls MA, et al
    Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis.
    Neurobiol Dis. 2020 May 17:104948. doi: 10.1016/j.nbd.2020.104948.
    PubMed     Abstract available

  2. HARJUHAAHTO S, Rasila TS, Molchanova SM, Woldegebriel R, et al
    ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human IPSC-derived motor neurons.
    Neurobiol Dis. 2020 May 8:104940. doi: 10.1016/j.nbd.2020.104940.
    PubMed     Abstract available

  3. ESPADAS I, Keifman E, Palomo-Garo C, Burgaz S, et al
    Beneficial effects of the phytocannabinoid Delta(9)-THCV in L-DOPA-induced dyskinesia in Parkinson's disease.
    Neurobiol Dis. 2020 May 5:104892. doi: 10.1016/j.nbd.2020.104892.
    PubMed     Abstract available

    April 2020
  4. BENOIT SM, Xu H, Schmid S, Alexandrova R, et al
    Expanding the search for genetic biomarkers of Parkinson's disease into the living brain.
    Neurobiol Dis. 2020 Apr 14:104872. doi: 10.1016/j.nbd.2020.104872.
    PubMed     Abstract available

    March 2020
  5. MOREAU C, Rolland AS, Pioli E, Li Q, et al
    Intraventricular dopamine infusion alleviates motor symptoms in a primate model of Parkinson's disease.
    Neurobiol Dis. 2020 Mar 20:104846. doi: 10.1016/j.nbd.2020.104846.
    PubMed     Abstract available

  6. PEREIRA JB, Hall S, Jalakas M, Grothe MJ, et al
    Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease.
    Neurobiol Dis. 2020 Mar 4:104831. doi: 10.1016/j.nbd.2020.104831.
    PubMed     Abstract available

    February 2020
  7. AMAN JE, Johnson LA, Sanabria DE, Wang J, et al
    Directional deep brain stimulation leads reveal spatially distinct oscillatory activity in the globus pallidus internus of Parkinson's disease patients.
    Neurobiol Dis. 2020 Feb 20:104819. doi: 10.1016/j.nbd.2020.104819.
    PubMed     Abstract available

  8. FAIVRE F, Sanchez-Catalan MJ, Dovero S, Bido S, et al
    Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson's disease.
    Neurobiol Dis. 2020 Feb 19:104818. doi: 10.1016/j.nbd.2020.104818.
    PubMed     Abstract available

    January 2020
  9. BANDRES-CIGA S, Diez-Fairen M, Kim JJ, Singleton AB, et al
    Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.
    Neurobiol Dis. 2020 Jan 25:104782. doi: 10.1016/j.nbd.2020.104782.
    PubMed     Abstract available

  10. SCHWAB AD, Thurston MJ, Machhi J, Olson KE, et al
    Immunotherapy for Parkinson's disease.
    Neurobiol Dis. 2020;137:104760.
    PubMed     Abstract available

  11. HULME H, Fridjonsdottir E, Gunnarsdottir H, Vallianatou T, et al
    Simultaneous mass spectrometry imaging of multiple neuropeptides in the brain and alterations induced by experimental parkinsonism and L-DOPA therapy.
    Neurobiol Dis. 2020 Jan 9:104738. doi: 10.1016/j.nbd.2020.104738.
    PubMed     Abstract available

  12. AIME P, Karuppagounder SS, Rao A, Chen Y, et al
    The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease.
    Neurobiol Dis. 2020 Jan 3:104725. doi: 10.1016/j.nbd.2019.104725.
    PubMed     Abstract available

    December 2019
  13. MARMOR O, Rappel P, Valsky D, Bick AS, et al
    Movement context modulates neuronal activity in motor and limbic-associative domains of the human parkinsonian subthalamic nucleus.
    Neurobiol Dis. 2019;136:104716.
    PubMed     Abstract available

  14. HENDERSON MX, Covell DJ, Chung CH, Pitkin RM, et al
    Characterization of novel conformation-selective alpha-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease.
    Neurobiol Dis. 2019 Dec 11:104712. doi: 10.1016/j.nbd.2019.104712.
    PubMed     Abstract available

  15. CHEN Z, Li G, Liu J
    Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment.
    Neurobiol Dis. 2019 Dec 3:104700. doi: 10.1016/j.nbd.2019.104700.
    PubMed     Abstract available

    November 2019
  16. SIKORA J, Kieffer BL, Paoletti P, Ouagazzal AM, et al
    Synaptic zinc contributes to motor and cognitive deficits in 6-hydroxydopamine mouse models of Parkinson's disease.
    Neurobiol Dis. 2019;134:104681.
    PubMed     Abstract available

  17. GIANGRASSO DM, Furlong TM, Keefe KA
    Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.
    Neurobiol Dis. 2019 Nov 14:104673. doi: 10.1016/j.nbd.2019.104673.
    PubMed     Abstract available

  18. MAASS F, Michalke B, Willkommen D, Leha A, et al
    Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease.
    Neurobiol Dis. 2019 Nov 13:104677. doi: 10.1016/j.nbd.2019.104677.
    PubMed     Abstract available

  19. BELVISI D, Pellicciari R, Fabbrini G, Tinazzi M, et al
    Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
    Neurobiol Dis. 2019;134:104671.
    PubMed     Abstract available

  20. MILLOT M, Saga Y, Duperrier S, Metereau E, et al
    Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys.
    Neurobiol Dis. 2019 Nov 2:104643. doi: 10.1016/j.nbd.2019.104643.
    PubMed     Abstract available

    October 2019
  21. AFLAKI E, Stubblefield BK, McGlinchey RP, McMahon B, et al
    A characterization of Gaucher iPS-derived astrocytes: Potential implications for Parkinson's disease.
    Neurobiol Dis. 2019 Oct 26:104647. doi: 10.1016/j.nbd.2019.104647.
    PubMed     Abstract available

  22. ROCHA EM, De Miranda BR, Castro S, Drolet R, et al
    LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease.
    Neurobiol Dis. 2019 Oct 13:104626. doi: 10.1016/j.nbd.2019.104626.
    PubMed     Abstract available

    September 2019
  23. CHEN CC, Yeh CH, Chan HL, Chang YJ, et al
    Subthalamic nucleus oscillations correlate with vulnerability to freezing of gait in patients with Parkinson's disease.
    Neurobiol Dis. 2019 Sep 5:104605. doi: 10.1016/j.nbd.2019.104605.
    PubMed     Abstract available

  24. RUSSO I, Kaganovich A, Ding J, Landeck N, et al
    Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with alpha-synuclein fibrils.
    Neurobiol Dis. 2019;129:67-78.
    PubMed     Abstract available

  25. FENYI A, Leclair-Visonneau L, Clairembault T, Coron E, et al
    Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification.
    Neurobiol Dis. 2019;129:38-43.
    PubMed     Abstract available

    August 2019
  26. CHATTERJEE D, Kordower JH
    Immunotherapy in Parkinson's disease: Current status and future directions.
    Neurobiol Dis. 2019 Aug 24:104587. doi: 10.1016/j.nbd.2019.104587.
    PubMed     Abstract available

  27. CALABRESI P, Standaert DG
    Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
    Neurobiol Dis. 2019;132:104579.
    PubMed     Abstract available

  28. DUTTA D, Kundu M, Mondal S, Roy A, et al
    RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease.
    Neurobiol Dis. 2019;132:104575.
    PubMed     Abstract available

  29. YOO SW, Oh YS, Hwang EJ, Ryu DW, et al
    "Depressed" caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson's disease.
    Neurobiol Dis. 2019 Aug 1:104563. doi: 10.1016/j.nbd.2019.104563.
    PubMed     Abstract available

  30. STEFANI A, Galati S
    PPN-DBS: A utopic vision or a realistic perspective?
    Neurobiol Dis. 2019;128:1-2.

  31. STEFANI A, Grandi LC, Galati S
    Deep brain stimulation of the pedunculopontine nucleus modulates subthalamic pathological oscillations.
    Neurobiol Dis. 2019;128:49-52.
    PubMed     Abstract available

  32. GUT NK, Mena-Segovia J
    Dichotomy between motor and cognitive functions of midbrain cholinergic neurons.
    Neurobiol Dis. 2019;128:59-66.
    PubMed     Abstract available

  33. NOWACKI A, Galati S, Ai-Schlaeppi J, Bassetti C, et al
    Pedunculopontine nucleus: An integrative view with implications on Deep Brain Stimulation.
    Neurobiol Dis. 2019;128:75-85.
    PubMed     Abstract available

  34. DI GIOVANNI G, Chagraoui A, Puginier E, Galati S, et al
    Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.
    Neurobiol Dis. 2019;128:9-18.
    PubMed     Abstract available

  35. GARCIA-RILL E, Mahaffey S, Hyde JR, Urbano FJ, et al
    Bottom-up gamma maintenance in various disorders.
    Neurobiol Dis. 2019;128:31-39.
    PubMed     Abstract available

    July 2019
  36. BURBULLA LF, Krainc D
    The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.
    Neurobiol Dis. 2019 Jul 25:104545. doi: 10.1016/j.nbd.2019.104545.
    PubMed     Abstract available

  37. CICCHETTI F, David LS, Siddu A, Denis HL, et al
    Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial.
    Neurobiol Dis. 2019 Jul 10:104530. doi: 10.1016/j.nbd.2019.104530.
    PubMed     Abstract available

  38. SHEHADEH J, Double KL, Murphy KE, Bobrovskaya L, et al
    Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.
    Neurobiol Dis. 2019 Jul 2:104524. doi: 10.1016/j.nbd.2019.104524.
    PubMed     Abstract available

  39. SINCLAIR NC, McDermott HJ, Fallon JB, Perera T, et al
    Deep brain stimulation for Parkinson's disease modulates high-frequency evoked and spontaneous neural activity.
    Neurobiol Dis. 2019 Jul 2:104522. doi: 10.1016/j.nbd.2019.104522.
    PubMed     Abstract available

  40. FISCHER P, Pogosyan A, Green AL, Aziz TZ, et al
    Beta synchrony in the cortico-basal ganglia network during regulation of force control on and off dopamine.
    Neurobiol Dis. 2019;127:253-263.
    PubMed     Abstract available

    June 2019
  41. MARIANI LL, Longueville S, Girault JA, Herve D, et al
    Differential enhancement of ERK, PKA and Ca(2+) signaling in direct and indirect striatal neurons of Parkinsonian mice.
    Neurobiol Dis. 2019 Jun 17:104506. doi: 10.1016/j.nbd.2019.104506.
    PubMed     Abstract available

    May 2019
  42. BOOTH HDE, Wessely F, Connor-Robson N, Rinaldi F, et al
    RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes.
    Neurobiol Dis. 2019 May 11. pii: S0969-9961(19)30120.
    PubMed     Abstract available

  43. SHETTY AS, Bhatia KP, Lang AE
    Dystonia and Parkinson's disease: What is the relationship?
    Neurobiol Dis. 2019 May 9. pii: S0969-9961(19)30107.
    PubMed     Abstract available

    April 2019
  44. CHOI DJ, An J, Jou I, Park SM, et al
    A Parkinson's disease gene, DJ-1, regulates anti-inflammatory roles of astrocytes through prostaglandin D2 synthase expression.
    Neurobiol Dis. 2019;127:482-491.
    PubMed     Abstract available

    March 2019
  45. LOFREDI R, Tan H, Neumann WJ, Yeh CH, et al
    Beta bursts during continuous movements accompany the velocity decrement in Parkinson's disease patients.
    Neurobiol Dis. 2019 Mar 18. pii: S0969-9961(19)30068.
    PubMed     Abstract available

    The impact of indigenous microbes on Parkinson's disease.
    Neurobiol Dis. 2019 Mar 15. pii: S0969-9961(19)30069.
    PubMed     Abstract available

    February 2019
  47. SHAHID M, Kim J, Leaver K, Hendershott T, et al
    An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Ass42 and an APOE epsilon4 allele.
    Neurobiol Dis. 2019 Feb 28. pii: S0969-9961(18)30655.
    PubMed     Abstract available

  48. KIRKLEY KS, Popichak KA, Hammond SL, Davies C, et al
    Genetic suppression of IKK2/NF-kappaB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson's disease.
    Neurobiol Dis. 2019 Feb 25. pii: S0969-9961(19)30050.
    PubMed     Abstract available

  49. SABIR MS, Blauwendraat C, Ahmed S, Serrano GE, et al
    Assessment of APOE in atypical parkinsonism syndromes.
    Neurobiol Dis. 2019 Feb 21. pii: S0969-9961(19)30046.
    PubMed     Abstract available

  50. MEIDAHL AC, Moll CKE, van Wijk B, Gulberti A, et al
    Synchronised spiking activity underlies phase amplitude coupling in the subthalamic nucleus of Parkinson's disease patients.
    Neurobiol Dis. 2019 Feb 9. pii: S0969-9961(19)30037.
    PubMed     Abstract available

    January 2019
  51. BADEN P, Yu C, Deleidi M
    Insights into GBA Parkinson's disease pathology and therapy with induced pluripotent stem cell model systems.
    Neurobiol Dis. 2019 Jan 31. pii: S0969-9961(19)30032.
    PubMed     Abstract available

  52. GLAAB E, Trezzi JP, Greuel A, Jager C, et al
    Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease.
    Neurobiol Dis. 2019 Jan 9. pii: S0969-9961(19)30002.
    PubMed     Abstract available

  53. MELLONE M, Zianni E, Stanic J, Campanelli F, et al
    NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology.
    Neurobiol Dis. 2019;121:338-349.
    PubMed     Abstract available

  54. GUNDNER AL, Duran-Pacheco G, Zimmermann S, Ruf I, et al
    Path mediation analysis reveals GBA impacts Lewy body disease status by increasing alpha-synuclein levels.
    Neurobiol Dis. 2019;121:205-213.
    PubMed     Abstract available

    December 2018
  55. DODIYA HB, Forsyth CB, Voigt RM, Engen PA, et al
    Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Dec 20. pii: S0969-9961(18)30768.
    PubMed     Abstract available

  56. MUS L, Siani F, Giuliano C, Ghezzi C, et al
    Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity.
    Neurobiol Dis. 2018 Dec 3. pii: S0969-9961(18)30756.
    PubMed     Abstract available

    November 2018
  57. HUANG YR, Xie XX, Ji M, Yu XL, et al
    Naturally occurring autoantibodies against alpha-synuclein rescues memory and motor deficits and attenuates alpha-synuclein pathology in mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Nov 24. pii: S0969-9961(18)30401.
    PubMed     Abstract available

  58. CHO SS, Christopher L, Koshimori Y, Li C, et al
    Decreased pallidal vesicular monoamine transporter type 2 availability in Parkinson's disease: The contribution of the nigropallidal pathway.
    Neurobiol Dis. 2018;124:176-182.
    PubMed     Abstract available

  59. REED X, Bandres-Ciga S, Blauwendraat C, Cookson MR, et al
    The role of monogenic genes in idiopathic Parkinson's disease.
    Neurobiol Dis. 2018 Nov 15. pii: S0969-9961(18)30668.
    PubMed     Abstract available

  60. IKEDA-MATSUO Y, Miyata H, Mizoguchi T, Ohama E, et al
    Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Neurobiol Dis. 2018 Nov 10. pii: S0969-9961(18)30741.
    PubMed     Abstract available

  61. SAMPEDRO F, Marin-Lahoz J, Martinez-Horta S, Pagonabarraga J, et al
    Dopaminergic degeneration induces early posterior cortical thinning in Parkinson's disease.
    Neurobiol Dis. 2018 Nov 5. pii: S0969-9961(18)30544.
    PubMed     Abstract available

  62. LAMONTAGNE-PROULX J, St-Amour I, Labib R, Pilon J, et al
    Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.
    Neurobiol Dis. 2018 Nov 5. pii: S0969-9961(18)30534.
    PubMed     Abstract available

  63. MILOSEVIC L, Gramer R, Kim TH, Algarni M, et al
    Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Neurobiol Dis. 2018 Nov 1. pii: S0969-9961(18)30593.
    PubMed     Abstract available

    October 2018
  64. WEIHOFEN A, Liu Y, Arndt JW, Huy C, et al
    Development of an aggregate-selective, human-derived alpha-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models.
    Neurobiol Dis. 2018 Oct 28. pii: S0969-9961(18)30448.
    PubMed     Abstract available

  65. HERNANDO S, Requejo C, Herran E, Ruiz-Ortega JA, et al
    Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation.
    Neurobiol Dis. 2018 Oct 5. pii: S0969-9961(18)30292.
    PubMed     Abstract available

    September 2018
  66. SOYAL SM, Zara G, Ferger B, Felder TK, et al
    The PPARGC1A locus and CNS-specific PGC-1alpha isoforms are associated with Parkinson's Disease.
    Neurobiol Dis. 2018 Sep 17. pii: S0969-9961(18)30591.
    PubMed     Abstract available

  67. PINA-FUENTES D, van Zijl JC, van Dijk JMC, Little S, et al
    The characteristics of pallidal low-frequency and beta bursts could help implementing adaptive brain stimulation in the parkinsonian and dystonic internal globus pallidus.
    Neurobiol Dis. 2018 Sep 15. pii: S0969-9961(18)30391.
    PubMed     Abstract available

  68. MAMMADOVA N, Summers CM, Kokemuller RD, He Q, et al
    Accelerated accumulation of retinal alpha-synuclein (pSer129) and tau, neuroinflammation and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
    Neurobiol Dis. 2018 Sep 12. pii: S0969-9961(18)30204.
    PubMed     Abstract available

  69. ANIDI CM, O'Day JJ, Anderson RW, Afzal MF, et al
    Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.
    Neurobiol Dis. 2018 Sep 6. pii: S0969-9961(18)30548.
    PubMed     Abstract available

    August 2018
  70. TUBERT C, Galtieri D, James Surmeier D
    The pedunclopontine nucleus and Parkinson's disease.
    Neurobiol Dis. 2018 Aug 29. pii: S0969-9961(18)30493.
    PubMed     Abstract available

  71. MOLONEY EB, Moskites A, Ferrari EJ, Isacson O, et al
    The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress.
    Neurobiol Dis. 2018 Aug 24. pii: S0969-9961(18)30484.
    PubMed     Abstract available

  72. GOETZ L, Piallat B, Bhattacharjee M, Mathieu H, et al
    Spike discharge characteristic of the caudal mesencephalic reticular formation and pedunculopontine nucleus in MPTP-induced primate model of Parkinson disease.
    Neurobiol Dis. 2018 Aug 4. pii: S0969-9961(18)30394.
    PubMed     Abstract available

    June 2018
    What is the therapeutic mechanism of pedunculopontine nucleus stimulation in Parkinson's disease?
    Neurobiol Dis. 2018 Jun 19. pii: S0969-9961(18)30193.
    PubMed     Abstract available

  74. TINKHAUSER G, Torrecillos F, Duclos Y, Tan H, et al
    Beta burst coupling across the motor circuit in Parkinson's disease.
    Neurobiol Dis. 2018 Jun 14. pii: S0969-9961(18)30182.
    PubMed     Abstract available

  75. TOZZI A, Durante V, Bastioli G, Mazzocchetti P, et al
    Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
    Neurobiol Dis. 2018 Jun 13. pii: S0969-9961(18)30185.
    PubMed     Abstract available

    May 2018
  76. POLAR CA, Gupta R, Lehmkuhle MJ, Dorval AD, et al
    Correlation between cortical beta power and gait speed is suppressed in a parkinsonian model, but restored by therapeutic deep brain stimulation.
    Neurobiol Dis. 2018 May 30. pii: S0969-9961(18)30151.
    PubMed     Abstract available

    April 2018
  77. PAN PY, Zhu Y, Shen Y, Yue Z, et al
    Crosstalk between presynaptic trafficking and autophagy in Parkinson's disease.
    Neurobiol Dis. 2018 Apr 30. pii: S0969-9961(18)30136.
    PubMed     Abstract available

  78. WANG H, Atik A, Stewart T, Ginghina C, et al
    Plasma alpha-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study.
    Neurobiol Dis. 2018 Apr 26. pii: S0969-9961(18)30123.
    PubMed     Abstract available

  79. ANDERSEN MA, Christensen KV, Badolo L, Smith GP, et al
    Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-alpha-synuclein is normalized by LRRK2 modulation.
    Neurobiol Dis. 2018 Apr 19. pii: S0969-9961(18)30119.
    PubMed     Abstract available

  80. DE MIRANDA BR, Rocha EM, Bai Q, El Ayadi A, et al
    Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    Neurobiol Dis. 2018 Apr 9. pii: S0969-9961(18)30116.
    PubMed     Abstract available

    March 2018
  81. GLEAVE JA, Arathoon LR, Trinh D, Lizal KE, et al
    Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146].
    Neurobiol Dis. 2018 Mar 20. pii: S0969-9961(18)30054.

  82. PITCAIRN C, Wani WY, Mazzulli JR
    Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.
    Neurobiol Dis. 2018 Mar 14. pii: S0969-9961(18)30074.
    PubMed     Abstract available

  83. PUSKA G, Lutz MI, Molnar K, Regelsberger G, et al
    Lysosomal response in relation to alpha-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Neurobiol Dis. 2018 Mar 2. pii: S0969-9961(18)30061.
    PubMed     Abstract available

    February 2018
  84. RIZZI N, Brunialti E, Cerri S, Cermisoni G, et al
    In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30037.
    PubMed     Abstract available

  85. PIERCE SE, Tyson T, Booms A, Prahl J, et al
    Parkinson's disease genetic risk in a midbrain neuronal cell line.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30039.
    PubMed     Abstract available

  86. WU HM, Li T, Wang ZF, Huang SS, et al
    Mitochondrial DNA variants modulate genetic susceptibility to Parkinson's disease in Han Chinese.
    Neurobiol Dis. 2018 Feb 24. pii: S0969-9961(18)30047.
    PubMed     Abstract available

    January 2018
  87. ALCALAY RN, Wolf P, Levy OA, Kang UJ, et al
    Alpha galactosidase A activity in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 21. pii: S0969-9961(18)30018.
    PubMed     Abstract available

  88. MERCADO G, Castillo V, Soto P, Lopez N, et al
    Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.
    Neurobiol Dis. 2018 Jan 17. pii: S0969-9961(18)30004.
    PubMed     Abstract available

  89. SHAROTT A, Gulberti A, Hamel W, Koppen JA, et al
    Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.
    Neurobiol Dis. 2018 Jan 4. pii: S0969-9961(18)30001.
    PubMed     Abstract available

  90. ALDRIN-KIRK P, Heuer A, Rylander Ottosson D, Davidsson M, et al
    Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
    Neurobiol Dis. 2018;109.
    PubMed     Abstract available

    December 2017
  91. NELSON MP, Boutin M, Tse TE, Lu H, et al
    The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.
    Neurobiol Dis. 2017;110:68-81.
    PubMed     Abstract available

    October 2017
  92. SPIGOLON G, Cavaccini A, Trusel M, Tonini R, et al
    cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease.
    Neurobiol Dis. 2017 Oct 28. pii: S0969-9961(17)30243.
    PubMed     Abstract available

    September 2017
  93. SYRKIN-NIKOLAU J, Koop MM, Prieto T, Anidi C, et al
    Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's disease.
    Neurobiol Dis. 2017 Sep 7. pii: S0969-9961(17)30214.
    PubMed     Abstract available

    August 2017
  94. BIOSA A, Sandrelli F, Beltramini M, Greggio E, et al
    Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease.
    Neurobiol Dis. 2017 Aug 17. pii: S0969-9961(17)30186.
    PubMed     Abstract available

    July 2017
  95. RYDBIRK R, Elfving B, Andersen MD, Langbol MA, et al
    Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients.
    Neurobiol Dis. 2017;106:269-278.
    PubMed     Abstract available

    June 2017
  96. ARATHOON LR, Gleave JA, Trinh D, Lizal KE, et al
    Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant alpha-synuclein rat model of parkinsonism.
    Neurobiol Dis. 2017 Jun 30. pii: S0969-9961(17)30136.
    PubMed     Abstract available

    May 2017
  97. GIESERT F, Glasl L, Zimprich A, Ernst L, et al
    The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
    Neurobiol Dis. 2017 May 30. pii: S0969-9961(17)30123.
    PubMed     Abstract available

    April 2017
  98. JULIENNE H, Buhl E, Leslie DS, Hodge JJL, et al
    Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.
    Neurobiol Dis. 2017 Apr 20. pii: S0969-9961(17)30088.
    PubMed     Abstract available

  99. CAVALIERE F, Cerf L, Dehay B, Ramos-Gonzalez P, et al
    In vitro alpha-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.
    Neurobiol Dis. 2017;103:101-112.
    PubMed     Abstract available

  100. ROCHA EM, De Miranda B, Sanders LH
    Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
    Neurobiol Dis. 2017 Apr 8. pii: S0969-9961(17)30080.
    PubMed     Abstract available

    March 2017
  101. LALOUX C, Gouel F, Lachaud C, Timmerman K, et al
    Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?
    Neurobiol Dis. 2017 Mar 28. pii: S0969-9961(17)30061.
    PubMed     Abstract available

    December 2016
  102. SONG L, McMackin M, Nguyen A, Cortopassi G, et al
    Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30314.
    PubMed     Abstract available

  103. MASILAMONI GJ, Groover O, Smith Y
    Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Neurobiol Dis. 2016 Dec 29. pii: S0969-9961(16)30315.
    PubMed     Abstract available

  104. VAINE CA, Shin D, Liu C, Hendriks W, et al
    X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Neurobiol Dis. 2016 Dec 22. pii: S0969-9961(16)30299.
    PubMed     Abstract available

  105. GENG X, Zhang J, Jiang Y, Ashkan K, et al
    Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia.
    Neurobiol Dis. 2016;98:100-107.
    PubMed     Abstract available

  106. KOZINA EA, Kim AR, Kurina AY, Ugrumov MV, et al
    Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Neurobiol Dis. 2016;98:108-121.
    PubMed     Abstract available

    September 2016
  107. NKILIZA A, Mutez E, Simonin C, Lepretre F, et al
    RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease.
    Neurobiol Dis. 2016 Sep 20. pii: S0969-9961(16)30230.
    PubMed     Abstract available

  108. KIRIK D, Cederfjall E, Halliday G, Petersen A, et al
    Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands.
    Neurobiol Dis. 2016 Sep 8. pii: S0969-9961(16)30222.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.